Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
15,633,927
-
Shares change
-
-652,450
-
Total reported value, excl. options
-
$1,758,540,556
-
Value change
-
-$96,543,968
-
Put/Call ratio
-
55%
-
Number of buys
-
81
-
Number of sells
-
-109
-
Price
-
$112.49
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q1 2022
236 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q1 2022.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,633,927 shares
of 19,667,509 outstanding shares and own 79% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,733,307 shares), VANGUARD GROUP INC (1,727,638 shares), JANUS HENDERSON GROUP PLC (1,389,067 shares), STATE STREET CORP (1,091,793 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (914,099 shares), MACQUARIE GROUP LTD (758,741 shares), VILLERE ST DENIS J & CO LLC (510,843 shares), Chicago Capital, LLC (491,717 shares), Stephens Investment Management Group LLC (417,670 shares), and DIMENSIONAL FUND ADVISORS LP (378,118 shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.